Bookmark Website  | Free Registration  | The Team
The Lounge  | Champions  | The Wire |  Schedule |  Audio  |  Arcade  |  The Top Ten  |  Historical  |  Email  |  Video

Reviving Vitamin E Studies That Challenge Claims of Wonder Supplement Also Leave Openings


The last year hasn't been a good one for vitamin E.

Once considered a wonder supplement, an inexpensive and harmless pill that might prevent heart disease, cancer and Alzheimer's, a flurry of recent clinical trials suggest it does none of those things.

Some even suggest there is a small chance it could be harmful in higher doses.

Yet while the oily little capsule apparently can't keep people alive longer, it refuses to die, in part because in nearly every one of the recent negative studies some caveat or contradictory finding creates a glimmer of hope.

It also doesn't hurt that the dietary supplement industry continues to promote vitamin E and offers experts to refute some of new research.

"It doesn't go away," said Edgar Miller, a vitamin E researcher and associate professor of medicine at Johns Hopkins University. "Why does it keep selling when there are so many of these negative studies?"

The answer appears to be a combination of factors, including years of promising laboratory, animal and epidemiological studies; heavy promotion by the dietary supplement industry; and, more recently, contradictory findings within studies showing no overall benefit.

The required daily amount is 22 IU (international units). Many recent clinical trials have ranged from 300 IU to 2,000 IU.

Recent clinical trials of high-dose vitamin E have led some researchers to speculate that vitamin E in megadoses may increase the oxidation of LDL cholesterol, the bad kind.

When cholesterol is oxidated, it contributes to coronary artery disease.

There also is some concern that high amounts of vitamin E may displace other beneficial anti-oxidants from that average person's diet.

Combining studies

Consider these recent studies: In November, a vitamin E bombshell was dropped by Johns Hopkins University researchers at an American Heart Association meeting.

They pooled 19 clinical trials of vitamin E involving 136,000 patients.

In 11 of the high-dose trials (400 IU or more), the risk of dying from any cause increased 4%, compared with people taking placebos.

Prior to that finding, vitamin E had been considered, at worst, harmless.

"People take anti-oxidants because they want to live longer," said Miller, an associate professor of medicine. "What we showed is you don't live longer."

However, the analysis also suggested that lower doses of vitamin E (less than 150 I.U. a day) were associated with about a 2% reduction in deaths.

Researchers acknowledged several potential shortcomings in their study.

For instance, they noted that several of the high-dose trials involved people with various chronic diseases and may not apply to healthy individuals.

They also said the small size of several of the trials in the analysis and inconsistent reporting of health events prevented a detailed look at the effect of various doses of the vitamin.

"It's a very flawed analysis," said Julie Buring, a professor of medicine at Harvard Medical School who recently presented her own vitamin E research.

She also said the 4% increased risk of death was not "clinically meaningful" and could be a chance finding.

Women's health study

On March 7, Buring and other Harvard scientists presented their own vitamin E study at the American College of Cardiology annual meeting.

Once again, the vitamin threw researchers a curve.

Analyzing data from the Women's Health Study, a trial involving 40,000 women who got either 600 IU of vitamin E every other day or a placebo, researchers found that it provided no overall cardiovascular benefit such as reduction in heart attacks or strokes.

However, an analysis of a subgroup of women over 65 found a 26% reduction in cardiovascular events.

Buring said that although the finding was "intriguing," it was not supported by previous research.

She added that it needs confirmation.

Adding even more confusion, the study found a statistically significant 24% reduction in cardiovascular deaths among all the vitamin E users.

Buring also questioned that finding because there was no overall reduction in strokes and heart attacks. She said it was possible that it was due to other cardiovascular causes such as arrhythmias or heart failure, but there was no reasonable biological explanation for that.

"People should look at that further, but it could be chance," she said.

Buring concluded that vitamin E was neither harmful nor beneficial in preventing cardiovascular disease.

A surprise

About a week after the Women's Health Study, another controversial vitamin E finding was presented.

The study involved 9,500 people aged 55 and older with vascular disease or diabetes who were followed for an average of seven years.

It found that 400 IU of vitamin E a day provided no protection against cancer or major vascular events such as heart attacks or strokes.

In addition, the study found a disturbing 13% increase in heart failure cases and 21% increase in heart failure hospitalizations.

That was the first time that vitamin E had been associated with an increased risk of heart failure, said lead author Eva Lonn, a professor of medicine at McMaster University in Hamilton, Ontario.

"I am not convinced about the harm," Lonn added.

Indeed, a recent small study of heart failure patients taking a cholesterol-lowering statin drug suggested that vitamin E actually increased the statin's ability to improve blood vessel function and lower inflammation.

Lonn and the other researchers said a review of all heart failure events in large vitamin E clinical trials "is strongly recommended."

Confounding the heart failure finding was what appeared to be a statistically significant 28% reduction in lung cancer cases, although in a secondary analysis of the data the benefit seemed to disappear.

"The numbers are small," Lonn said. "We think it's a chance finding."

The researchers noted that other larger vitamin E trials showed no lung cancer benefit.

Alzheimer's research

There still is some hope that vitamin E might help prevent Alzheimer's disease, although in May a clinical trial of 769 patients with mild cognitive impairment found it was of no benefit in delaying the progression to Alzheimer's.

In that trial, the patients took a mega dose 2,000 IU a day for up to three years, according to the findings in the New England Journal of Medicine.

Other vitamin E / Alzheimer's trials are ongoing.

The anti-oxidant vitamin enthusiasm of the 1990s is being tempered by clinical trials, according to a JAMA editorial that accompanied the Women's Health Study results.

"These hopes are now confined to modest expectations for specific disorders and there are concerns about adverse effects," the editorial said.

Mike Freije from Health Shop
http://www.health-shop.com
http://www.health-shop.info


MORE RESOURCES:

FDA warning about male enhancement supplements
AZFamily
PHOENIX -- The U.S. Food and Drug Administration has a warning about supplements that claim to enhance male sexual performance. The FDA says some of those products are deceptive and potentially could even be deadly. The FDA warns that 20 herbal ...



Newsworks.org

Better state regulation of dietary supplements needed, Temple study finds
Newsworks.org
A public-health lawyer at Temple University says individual states need to step in an area where the federal government has failed -- regulating the marketing of supplements sold for weight-loss and muscle building. Jennifer Pomeranz, from Temple's ...

and more »


Mango supplements improved blood glucose control in adults with obesity
Healio
Lucas and colleagues conducted a 3-month pilot study involving 20 adults (11 men, nine women; aged 20-50 years) with obesity (BMI, 30-45 kg/m2) to investigate the effects of mango supplementation on anthropometrics, body composition and biochemical ...

and more »


India Named Prime Demand for Quality Nutritional Supplements by Matt Argall
MarketWatch
MIAMI, FL, Sep 28, 2014 (Marketwired via COMTEX) -- According to a recent article in Digital Marketplace the demand for nutritional supplements in India is growing. Projections looking into 2017 support this positive growth outlook and overall forward ...

and more »


MinnPost

Study ties herbal and dietary supplements to serious liver damage
MinnPost
The number of liver injuries associated with supplements is still much, much lower than those attributed to conventional medications, but, proportionally, supplements are significantly more likely to lead to serious injuries that result in a liver ...



Thyroid Issues? What You Need to Know About Diet and Supplements
Health Hub from Cleveland Clinic
Among the foods that thyroid patients should go easy on — if not avoid altogether — are soy, kelp and dietary supplements like iodine and selenium, says endocrinologist Christian Nasr, MD. “There is a lot of literature on what people shouldn't do ...



New York Daily News

Supplements cause more liver damage, decadelong study finds
New York Daily News
"While many Americans believe supplements to be safe, government … require less safety evidence to market products than what is required for conventional pharmaceuticals," lead author Dr. Victor Navarro, from Einstein Medical Center Philadelphia, said ...
Supplements now more likely than medications to cause deathConsumerAffairs
Dietary, Herbal Supplements Lead To Liver Damage 20% Of The TimeMedical Daily
NPA Responds to Study on Liver Damage From SupplementsNatural Products INSIDER
Science 2.0 -TheHealthSite
all 28 news articles »


For ADHD, supplements hold limited promise
Yale Daily News (blog)
Nutritional supplements may not be the answer to treating ADHD, according to a new analysis from the Yale Child Study Center. Michael Bloch, a professor at the Center, recently published a summary of existing studies on the efficacy of various ...



Temple University News

States should increase regulation of dietary supplements, Temple study finds
Temple University News
Dietary supplements, which are marketed to adults and adolescents for weight loss and muscle building, usually do not deliver promised results and can actually cause severe health issues, including death. But because of lax federal oversight of these ...



Why you can skip the memory supplements
KOMO News
"No one has been able to show that any of these special supplements that are marketed to improve your memory or boost your memory or keep your sharp, have any effect on what happens to you mentally as you age,” said Jamie Kopf, editor of Consumer ...


Google News


Advertisement



Section Site Map - Submit News - Feedback - Comments - Advertise with Us

Copyright 2006 Luminati Inc. All rights reserved.